Explore the latest developments concerning FDA Approves New.
New menopause drug to target hot flashes without hormones gets FDA approval
(CNN) — The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.
The drug, elinzanetant, is expected to be available in the United States beginning in November under the brand name Lynkuet, Bayer said.
It works by blocking the brain chemicals responsible for hot flashes and night sweats – what doctors call vasomotor symptoms – in menopausal women. It’s estimated that more than 80% of women have hot flashes during menopause.
“This FDA approval represents a bold step forward – our first hormone-free treatment for alleviating vasomotor symptoms of menopause,” Christine Roth, Bayer’s executive vice president of global product strategy and commercialization, said in a news release Friday.
JUCIAO USAPA Approved Thermoformed Unibody T700 Raw Carbon Fiber Pickleball Paddle Spin Textured Surface With Foam Edge
The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.